[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc (VINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal

Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued...

VINC : 0.0151 (+18.90%)
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders

VINC : 0.0151 (+18.90%)
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal

VINC : 0.0151 (+18.90%)
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC

VINC : 0.0151 (+18.90%)
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

VINC : 0.0151 (+18.90%)
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

VINC : 0.0151 (+18.90%)
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

VINC : 0.0151 (+18.90%)
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258

VINC : 0.0151 (+18.90%)
Vincerx Pharma, Inc. Announces Reverse Stock Split

VINC : 0.0151 (+18.90%)
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish

Retail sentiment on Stocktwits has remained ‘bullish’ on the stock.

VINC : 0.0151 (+18.90%)
VXF : 239.53 (-0.32%)
VTI : 370.58 (-0.49%)

Barchart Exclusives

Warren Buffett Might Prefer Apple Over Alphabet Stock, But Wall Street Disagrees
Warren Buffett has disclosed that it was he who initiated the position in Alphabet last year, even though he does not find it to be the best business in the conglomerate's portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.